Impacts of Canada's Minimum Age for Tobacco Sales (MATS) Laws on Youth Smoking Behaviour, 2000-2014
Overview
Authors
Affiliations
Background: Recently, the US Institute of Medicine has proposed that raising the minimum age for tobacco purchasing/sales to 21 years would likely lead to reductions in smoking behavior among young people. Surprisingly few studies, however, have assessed the potential impacts of minimum-age tobacco restrictions on youth smoking.
Objective: To estimate the impacts of Canadian minimum age for tobacco sales (MATS) laws on youth smoking behaviour.
Design: A regression-discontinuity design, using seven merged cycles of the Canadian Community Health Survey, 2000-2014.
Participants: Survey respondents aged 14-22 years (n=98 320).
Exposure: Current Canadian MATS laws are 18 years in Alberta, Saskatchewan, Manitoba, Quebec, the Yukon and Northwest Territories, and 19 years of age in the rest of the country.
Main Outcomes: Current, occasional and daily smoking status; smoking frequency and intensity; and average monthly cigarette consumption.
Results: In comparison to age groups slightly younger than the MATS, those just older had significant and abrupt increases immediately after the MATS in the prevalence of current smokers (absolute increase: 2.71%; 95% CI 0.70% to 4.80%; P=0.009) and daily smokers (absolute increase: 2.43%; 95% CI 0.74% to 4.12%; P=0.005). Average past-month cigarette consumption within age groups increased immediately following the MATS by 18% (95% CI 3% to 39%; P=0.02). There was no evidence of significant increases in smoking intensity for daily or occasional smokers after release from MATS restrictions.
Conclusion: The study provides relevant evidence supporting the effectiveness of Canadian MATS laws for limiting smoking among tobacco-restricted youth.
Reid J, Burkhalter R, Kasza K, Seo Y, East K, Hyland A Int J Drug Policy. 2023; 115:104003.
PMID: 36965305 PMC: 10370475. DOI: 10.1016/j.drugpo.2023.104003.
Hawkins S, Chung-Hall J, Craig L, Fong G, Borland R, Cummings K Nicotine Tob Res. 2020; 22(12):2266-2270.
PMID: 32609835 PMC: 7733059. DOI: 10.1093/ntr/ntaa119.
Beard E, Brown J, Jackson S, West R, Anderson W, Arnott D BMC Med. 2020; 18(1):85.
PMID: 32264873 PMC: 7140583. DOI: 10.1186/s12916-020-01541-w.